Abstract | OBJECTIVE: METHODS: RESULTS: As the treatment proceeded, symptom scores decreased in both groups; on the third day of treatment, all symptom scores except cough score showed a significant decrease in both groups (P<0.05), but the tulobuterol group had significantly lower symptom scores than the salbutamol group (P<0.05). On the fourteenth day of treatment, both groups had a significant decrease in cough score (P<0.05), but the tulobuterol group had a significantly lower cough score than the salbutamol group (P<0.05). One child developed hand trembling in the salbutamol group, while no adverse event occurred in the tulobuterol group. CONCLUSIONS: Compared with oral salbutamol sulfate, tulobuterol patch has a better therapeutic efficacy and a higher safety in children with mild or moderate acute asthmatic attack.
|
Authors | Qian Lin, Quan-Hua Liu, Yi-Xiao Bao |
Journal | Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
(Zhongguo Dang Dai Er Ke Za Zhi)
Vol. 15
Issue 6
Pg. 462-5
(Jun 2013)
ISSN: 1008-8830 [Print] China |
PMID | 23791063
(Publication Type: Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adrenergic beta-2 Receptor Agonists
- tulobuterol
- Terbutaline
- Albuterol
|
Topics |
- Acute Disease
- Administration, Oral
- Adrenergic beta-2 Receptor Agonists
(therapeutic use)
- Albuterol
(administration & dosage, adverse effects, therapeutic use)
- Asthma
(drug therapy)
- Female
- Humans
- Terbutaline
(administration & dosage, adverse effects, analogs & derivatives, therapeutic use)
|